Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
The DNA damage response (DDR) pathway and ARF function as barriers to cancer development. Although commonly regarded as operating independently of each other, some studies proposed that ARF is positively regulated by the DDR. Contrary to either scenario, we found that in human oncogene-transformed and cancer cells, ATM suppressed ARF protein levels and activity in a transcription-independent manner. Mechanistically, ATM activated protein phosphatase 1, which antagonized Nek2-dependent phosphorylation of nucleophosmin (NPM), thereby liberating ARF from NPM and rendering it susceptible to degradation by the ULF E3-ubiquitin ligase. In human clinical samples, loss of ATM expression correlated with increased ARF levels and in xenograft and tissue culture models, inhibition of ATM stimulated the tumour-suppressive effects of ARF. These results provide insights into the functional interplay between the DDR and ARF anti-cancer barriers, with implications for tumorigenesis and treatment of advanced tumours.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a tight regulatory network in human cancer models was reported, whereby ATM suppresses ARF levels and ARF acts as a secondary barrier to cancer progression when ATM is inactivated31”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [31]
In the citing paper
“DDR precedes ARF engagement, whose activation is detected at later stages of cancer progression and less frequently than DDR”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [31]
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Genomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397
Self-citationActivation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Self-citation
Cited by
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Senescence and apoptosis: dueling or complementary cell fates?
Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J., & van Deursen, J. M. (2014) · The EMBO Reports · doi:10.15252/embr.201439245 · Cited by 915
“However, ATM can suppress ARF in some cancer cells, so the final effect on cell cycle progression depends on the balance between upstream signals [9].”
p21: a two-faced genome guardian.
Georgakilas, A. G., Martin, O. A., & Bonner, W. M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.02.001 · Cited by 489
Galanos, P., Vougas, K., Walter, D., Polyzos, A., Maya-Mendoza, A., Haagensen, E. J., Kokkalis, A., Roumelioti, F.-M., Gagos, S., Tzetis, M., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3378 · Cited by 308
Self-citationRegulation of the p53 response and its relationship to cancer
Meek, D. W. (2015) · Biochemical Journal · doi:10.1042/bj20150517 · Cited by 288
Mladenov, E., Magin, S., Soni, A., & Iliakis, G. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.03.003 · Cited by 250
Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis
Lindström, M. S., Jurada, D., Bursac, S., Orsolic, I., Bartek, J., & Volarevic, S. (2018) · Oncogene · doi:10.1038/s41388-017-0121-z · Cited by 238
“This allows ARF to translocate to the nucleus where it is degraded by the ubiquitin ligase of ARF (ULF) [135].”
BackgroundStructural polymorphism in the N-terminal oligomerization domain of NPM1
Mitrea, D. M., Grace, C. R., Buljan, M., Yun, M.-K., Pytel, N. J., Satumba, J., Nourse, A., Park, C.-G., Madan Babu, M., White, S. W., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321007111 · Cited by 192
“dk/services/NetPhosK/), and ATM and Aurora (19)] (24) and Ser88 (known Nek2 kinase site) (22, 49).”
BackgroundDNA Damage Response and Autophagy: A Meaningful Partnership
Eliopoulos, A. G., Havaki, S., & Gorgoulis, V. G. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00204 · Cited by 169
“In this regard, a recent study has shown that smARF overexpression depolarizes mitochondria and promotes mitophagy in a Parkin/PINK1-dependent manner (Grenier et al., 2014); the relevance of this finding to DNA damage-induced senescence requires additional studies.”
BackgroundInfluentialSelf-citationThe relationship between the nucleolus and cancer: Current evidence and emerging paradigms
Orsolic, I., Jurada, D., Pullen, N., Oren, M., Eliopoulos, A. G., & Volarevic, S. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.12.004 · Cited by 168
Senescence and senotherapeutics: a new field in cancer therapy
Myrianthopoulos, V., Evangelou, K., Vasileiou, P. V. S., Cooks, T., Vassilakopoulos, T. P., Pangalis, G. A., Kouloukoussa, M., Kittas, C., Georgakilas, A. G., & Gorgoulis, V. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.006 · Cited by 160
Self-citationPateras, I. S., Havaki, S., Nikitopoulou, X., Vougas, K. N., Townsend, P. A., Panayiotidis, M. I., Georgakilas, A. G., & Gorgoulis, V. G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.011 · Cited by 156
“This would lead to downregulation of FasL and concurrently ARF induction by hindering ATM activity (Velimezi et al., 2013), which can eventually suppress VEGF-A, as previously reported (Kotsinas et al., 2014).”
BackgroundResultSelf-citationNikitaki, Z., Mavragani, I. V., Laskaratou, D., Gika, V., Moskvin, V. P., Theofilatos, K., Vougas, K. N., Stewart, R. D., & Georgakilas, A. G. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.02.002 · Cited by 142
Self-citationThe role of oxidative DNA damage in radiation induced bystander effect
Havaki, S., Kotsinas, A., Chronopoulos, E., Kletsas, D., Georgakilas, A. G., & Gorgoulis, V. G. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.023 · Cited by 134
Self-citationSystemic DNA damage responses in aging and diseases
Ribezzo, F., Shiloh, Y., & Schumacher, B. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.12.005 · Cited by 116
“ATM also impacts tumor suppression through the senescence regulator ARF [41], which in turn impacts NF-κB and p53 through the DDR kinases ATR and CHK1 [42].”
InfluentialIntegrating the DNA damage and protein stress responses during cancer development and treatment
Gorgoulis, V. G., Pefani, D., Pateras, I. S., & Trougakos, I. P. (2018) · The Journal of Pathology · doi:10.1002/path.5097 · Cited by 108
“A cc ep te d A rti cl e characteristic example is p53 activation following nucleolar segregation (ribosomal stress*) upon DNA damage or transcription inhibition (Figure S4A) [172-174].”
BackgroundInfluentialSelf-citationInflammation, DNA Damage, Helicobacter pylori and Gastric Tumorigenesis
Kalisperati, P., Spanou, E., Pateras, I. S., Korkolopoulou, P. A., Varvarigou, A. A., Karavokyros, I., Gorgoulis, V. G., Vlachoyiannopoulos, P. G., & Sougioultzis, S. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00020 · Cited by 127
“Notably, the DDR pathway, through its upstream kinase ATM, also keeps in check another major tumor suppressor factor, namely p14ARF (Velimezi et al., 2013; Wallace et al., 2014) that functions as a second antitumor barrier to DDR activation (Evangelou et al., 2013).”
BackgroundSelf-citationLi, Z., Zhang, W., Chen, Y., Guo, W., Zhang, J., Tang, H., Xu, Z., Zhang, H., Yi, T., Wang, F., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.65 · Cited by 125
“Indeed, a recent report indicates that ATM, the major sensor of DNA DSBs, suppresses the protein stability of ARF, which may trigger the onset of cellular senescence.(41) This suggests that there is a functional interplay between genome integrity and cellular senescence.”
BackgroundKorsholm, L. M., Gál, Z., Lin, L., Quevedo, O., Ahmad, D. A., Dulina, E., Luo, Y., Bártek, J., & Larsen, D. H. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz518 · Cited by 114
“The consequences of a compromised nucleolar-DDR still await further investigations both with regards to cell physiology and its suggested involvement in disease (47).”
Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma
Franqui-Machin, R., Hao, M., Bai, H., Gu, Z., Zhan, X., Habelhah, H., Jethava, Y. S., Qiu, L., Frech, I., Tricot, G. J. K., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98765 · Cited by 97
Effects of hyperthermia as a mitigation strategy in DNA damage-based cancer therapies
Mantso, T., Goussetis, G., Franco, R., Botaitis, S., Pappa, A., & Panayiotidis, M. I. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.03.004 · Cited by 87
Cellular senescence in the aging brain: A promising target for neurodegenerative diseases
Sahu, M. R., Rani, L., Subba, R., & Mondal, A. C. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111675 · Cited by 75
Harel, S. A., Moshe, N. B. B., Aylon, Y., Bublik, D. R., Moskovits, N. B.-C., Toperoff, G., Azaiza, D., Biagoni, F., Fuchs, G., Wilder, S., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2014.221 · Cited by 83
“HBECs immortalized with hTERT+Cdk4(51) were grown in keratinocyte serum-free medium (Invitrogen, Grand Island, NY, USA) supplemented with 50 μg/ml bovine Pituitary extract and 5 ng/ml hEGF (Invitrogen).(52) 5′aza-deoxycytidine (5′aza; MP Bio-Med, Santa Ana, CA, USA) was dissolved in acetic acid:H2O.”
Kyjacová, L., Hubáčková, S., Krejčíková, K., Strauss, R., Hanzlíková, H., Dzijak, R., Imrichová, T., Simova, J., Reiniš, M., Bártek, J., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.97 · Cited by 76
“To produce DU145-empty and DU145-Bcl-XL cell lines, DU145 cells were transduced either with pCDH-CMV-MCS-EFI-Neo or with pCDH-EFI-Neo-Bcl-XL viral particles.(68) For inducible RNAi of Snail, DU145 were transduced with pLKO-TetOn-shRNA-Snail particles.”
MethodBoyer, A.-S., Walter, D., & Sørensen, C. S. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.01.001 · Cited by 79
Senescence: A DNA damage response and its role in aging and Neurodegenerative Diseases
Shreeya, T., Ansari, M. S., Kumar, P., Saifi, M., Shati, A. A., Alfaifi, M. Y., & Elbehairi, S. E. I. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1292053 · Cited by 83
E3 Ubiquitin Ligase TRIP12: Regulation, Structure, and Physiopathological Functions
Brunet, M., Vargas, C., Larrieu, D., Torrisani, J., & Dufresne, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228515 · Cited by 78
“discovered that the key DDR kinase ATM negatively regulates the abundance of ARF with the implication of TRIP12 [118].”
BackgroundTargeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer
Li, L., Zhu, T., Gao, Y., Zheng, W., Wang, C., Xiao, L., Huang, M., Yin, J., Zhou, H., & Liu, Z. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060839 · Cited by 70
“ATM can suppress ARF protein levels and activity in a transcription-independent manner [62,63].”
BackgroundWang, L., Liu, R., Ye, P., Wong, C.-S., Chen, G., Zhou, P., Sakabe, K., Zheng, X., Wu, W., Zhang, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms6909 · Cited by 66
DNA Damage: From Chronic Inflammation to Age-Related Deterioration
Ιωαννίδου, Ά., Goulielmaki, E., & Garinis, G. A. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00187 · Cited by 69
“This inherent complexity arising from manifold levels of organization within multicellular life forms requires that genome maintenance, the DNA damage response (DDR) and defense strategies are tightly linked (Velimezi et al., 2013) and highly coordinated processes (Figure 1).”
BackgroundYi, Y., Kang, H., & Bae, I. (2014) · Cancers · doi:10.3390/cancers6020771 · Cited by 60
“Interestingly, a recent report demonstrated that ATM kinase negatively regulates ARF by ubiquitin-dependent degradation: ATM-activated protein phosphatase 1 (PP1) antagonized Nek2-dependent phosphorylation of nucleophosmin (NPM) to liberate ARF from NPM and render it susceptible to degradation by the ULF E3-ubiquitin…”
BackgroundRole of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression
Wang, J., Ding, S., Duan, Z., Xie, Q., Zhang, T., Zhang, X., Wang, Y., Chen, X., Zhuang, H., & Lu, F. (2015) · Oncogene · doi:10.1038/onc.2015.234 · Cited by 62
Zhang, J., Gambin, T., Yuan, B., Szafrański, P., Rosenfeld, J. A., Balwi, M. A. A., Alswaid, A. F., Al‐Gazali, L., Al-Shamsi, A. M., Komara, M., et al. (2017) · Human Genetics · doi:10.1007/s00439-017-1763-1 · Cited by 63
“…for TRIP12, including amyloid precursor protein-binding protein (APP-BP1) (Park et al. 2008); ADPribosylation factor 1 (ARF) (Chen et al. 2013; Velimezi et al. 2013); pancreas transcription factor 1a (PTF1a) (Hanoun et al. 2014); SRY (Sex determining region Y)Box 6 (SOX6) HECT, UBA, and WWE…”
BackgroundRepression of phosphoglycerate dehydrogenase sensitizes triple-negative breast cancer to doxorubicin
Zhang, X., & Bai, W. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3117-4 · Cited by 57
Regulators in the DNA damage response
Liu, Y., Li, Y., & Lu, X. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.02.018 · Cited by 64
Oršolić, I., Bursać, S., Jurada, D., Hofman, I. D., Dembić, Z., Bártek, J., Mihalek, I., & Volarević, S. (2020) · Oncogene · doi:10.1038/s41388-020-1231-6 · Cited by 55
Dual Role of the Alternative Reading Frame ARF Protein in Cancer
Fontana, R., Ranieri, M., Mantia, G. L., & Vivo, M. (2019) · Biomolecules · doi:10.3390/biom9030087 · Cited by 58
“DNA damage Activation of ATM/ATR/CHK pathway, p53-dependent pathways of DNA repair [115,116]”
BackgroundGuo, Z., Zhang, Y., Gong, Y., Li, G., Pan, J., Dou, D., Ma, K., Cui, C., Liu, Y., & Zhu, X. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.029 · Cited by 56
TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects
Wang, L., Zhang, P., Molkentine, D. P., Chen, C., Molkentine, J. M., Piao, H., Raju, U., Zhang, J., Valdecanas, D. R., Tailor, R. C., et al. (2016) · Oncogene · doi:10.1038/onc.2016.250 · Cited by 56
Chromá, K., Mistrík, M., Moudrý, P., Gurský, J., Liptay, M., Strauss, R., Škrott, Z., Vrtěl, R., Bártková, J., Kramara, J., et al. (2016) · Oncogene · doi:10.1038/onc.2016.392 · Cited by 53
Trip12 is an E3 ubiquitin ligase for USP 7/HAUSP involved in the DNA damage response
Liu, X., Yang, X., Li, Y., Zhao, S., Li, C., Ma, P., & Mao, B. (2016) · FEBS Letters · doi:10.1002/1873-3468.12471 · Cited by 51
Komseli, E.-S., Pateras, I. S., Krejsgaard, T., Stawiski, K., Rizou, S. V., Polyzos, A., Roumelioti, F.-M., Chiourea, M., Mourkioti, I., Paparouna, E., et al. (2018) · BMC Genomics · doi:10.1186/s12864-017-4375-1 · Cited by 51
Self-citationRole of genomic instability in human carcinogenesis
Moon, J. J., Lu, A., & Moon, C. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219826031 · Cited by 54
Carlos, A. R., Escandell, J. M., Kotsantis, P., Suwaki, N., Bouwman, P., Badie, S., Folio, C., Benitez, J. J., Goméz-López, G., Pisano, D. G., et al. (2013) · Nature Communications · doi:10.1038/ncomms3697 · Cited by 52
Chakraborty, S., Mir, K. B., Seligson, N. D., Nayak, D., Kumar, R., & Goswami, A. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09866-x · Cited by 47
Exploring and exploiting the systemic effects of deregulated replication licensing
Petrakis, T. G., Komseli, E.-S., Papaioannou, M. D., Vougas, K., Polyzos, A., Myrianthopoulos, V., Mikros, E., Trougakos, I. P., Thanos, D., Branzei, D., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.12.002 · Cited by 52
Self-citationThe Mre11 Complex Suppresses Oncogene-Driven Breast Tumorigenesis and Metastasis
Gupta, G. P., Vanness, K., Barlas, A., Manova-Todorova, K. O., Wen, Y. H., & Petrini, J. H. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.001 · Cited by 45
Turi, Z., Šenkyříková, M., Mistrík, M., Bártek, J., & Moudrý, P. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1403685 · Cited by 44
“nent of the DDR network and negatively regulates abundance of the alternative reading frame (ARF) tumor suppressor protein [41].”
BackgroundDNA damage stress induces the expression of Ribosomal Protein S27a gene in a p53-dependent manner
Nosrati, N., Kapoor, N. R., & Kumar, V. (2015) · Gene · doi:10.1016/j.gene.2015.01.014 · Cited by 42
Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer
Feng, Y., Su, Y., Lin, S.-F., Lin, P., Wu, C., Tung, C.-L., Li, C., Shieh, G.-S., & Shiau, A. (2019) · BMC Cancer · doi:10.1186/s12885-019-6014-5 · Cited by 43
Regulation and roles of Cdc7 kinase under replication stress
Yamada, M., Masai, H., & Bártek, J. (2014) · Cell Cycle · doi:10.4161/cc.29251 · Cited by 49
Proteome Stability as a Key Factor of Genome Integrity
Gumeni, S., Evangelakou, Z., Gorgoulis, V., & Trougakos, I. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102036 · Cited by 42
“The activation of checkpoint kinases triggers a phosphorylation cascade that affects (among many other factors) the tumor suppressor p53, which turns on the transcription of downstream targets, leading to arrest of cell cycle, DNA repair and/or senescence [33,35].”
BackgroundSelf-citationWWOX modulates the ATR-mediated DNA damage checkpoint response
Abu-Odeh, M., Heerema, N. A., & Aqeilan, R. I. (2015) · Oncotarget · doi:10.18632/oncotarget.6571 · Cited by 40
“e increased levels of tumor suppressor ARF [48].”
CHMP4C Disruption Sensitizes the Human Lung Cancer Cells to Irradiation
Li, K., Liu, J., Tian, M., Gao, G., Qi, X., Pan, Y., Ruan, J., Liu, C., & Su, X. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010018 · Cited by 37
“Contrary to the function of CHMP4C on cell fate, inhibition of ATM enhances ARF levels and stimulates the tumor-suppressive effects of ARF in human oncogene-transformed and cancer cells [24].”
BackgroundYeganeh, M., Gui, Y., Kandhi, R., Bobbala, D., Tobelaim, W.-S., Saucier, C., Yoshimura, A., Ferbeyre, G., Ramanathan, S., & Ilangumaran, S. (2016) · Oncogene · doi:10.1038/onc.2015.485 · Cited by 46
Luna‐Vital, D. A., de Mejía, E. G., & Loarca-Piña, G. F. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.02.021 · Cited by 40
Pefani, D., Tognoli, M. L., Ercan, D. P., Gorgoulis, V. G., & O’Neill, E. E. (2018) · The EMBO Journal · doi:10.15252/embj.201798760 · Cited by 42
“Recent observations have highlighted also the importance of ATM in Pol I regulation in response to DNA damage via Nbs1-Treacle-and ARF-dependent interactions (Kruhlak et al , 2007; Velimezi et al , 2013; Larsen et al , 2014; Harding et al , 2015).”
Self-citationDNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase
Bražina, J., Švadlenka, J., Macůrek, L., Anděra, L., Hodný, Z., Bártek, J., & Hanzlíková, H. (2015) · Cell Cycle · doi:10.4161/15384101.2014.988019 · Cited by 38
“Furthermore, recent studies have revealed coordinated roles of the DNA damage response and the ARF tumor suppressor pathway in their biological barrier functions against activated oncogenes and cancer progression.(59-61) Activated oncogenes evoke replication stress and endogenous DNA damage characterized by enhanced D…”
Oncoprotein Tudor-SN is a key determinant providing survival advantage under DNA damaging stress
Fu, X., Zhang, C., Meng, H., Zhang, K., Shi, L., Cao, C., Wang, Y., Su, C., Xin, L., Ren, Y., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0068-9 · Cited by 36
“Although DDR and the alternative reading frame (ARF) are commonly considered to function independently, it was reported recently that inhibition of ATM correlated with increased ARF levels and stimulated the tumour-suppressive effects [46].”
BackgroundConsequences of irradiation on adult spermatogenesis: Between infertility and hereditary risk
Marjault, H., & Allemand, I. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.07.004 · Cited by 34
Cellular senescence and failure of myelin repair in multiple sclerosis
Koutsoudaki, P. N., Papadopoulos, D., Passias, P.-G., Koutsoudaki, P., & Gorgoulis, V. G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111366 · Cited by 33
Self-citationRegulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress
Xie, N., Ma, L., Zhu, F., Zhao, W., Tian, F., Yuan, F., Fu, J., Huang, D., Lv, C., & Tong, T. (2016) · Scientific Reports · doi:10.1038/srep36171 · Cited by 31
Tumor Suppressor Genes within Common Fragile Sites Are Active Players in the DNA Damage Response
Hazan, I., Hofmann, T. G., & Aqeilan, R. I. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006436 · Cited by 35
Tug of War between Survival and Death: Exploring ATM Function in Cancer
Stagni, V., Oropallo, V., Fianco, G., Antonelli, M., Cinà, I., & Barilà, D. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045388 · Cited by 36
“In human clinical samples, loss of ATM expression correlated with higher ARF protein levels and in xenograft experiments inhibition of ATM promotes the tumor-suppressive function of ARF [52].”
BackgroundInfluentialKang, H., Lim, J. W., & Kim, H. (2018) · Journal of Ginseng Research · doi:10.1016/j.jgr.2018.08.003 · Cited by 30
“ATM activation is related with increased ARF levels in the studies using ATM-null mouse embryo fibroblasts andmice [36], ARF-null mouse embryo fibroblasts and mice [37], and human cancer cells and tissue culture models [38].”
BackgroundNon-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis
Lаgopati, N., Belogiannis, K., Angelopoulou, A., Papaspyropoulos, A., & Gorgoulis, V. G. (2021) · Biomolecules · doi:10.3390/biom11010086 · Cited by 33
“Although ATM inhibits ARF [15], both RASSF1A and ARF prevent MDM2-mediated”
BackgroundSelf-citationGuerra, B., Iwabuchi, K., & Issinger, O. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.008 · Cited by 35
Mutant p53 induces SIRT3/MnSOD axis to moderate ROS production in melanoma cells
Torrens‐Mas, M., Cordani, M., Mullappilly, N., Pacchiana, R., Riganti, C., Palmieri, M., Pons, D. G., Roca, P., Oliver, J., & Donadelli, M. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108219 · Cited by 30
The MRE11 complex: An important source of stress relief
Rein, K., & Stracker, T. H. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.10.010 · Cited by 31
Inhibition of GOT1 sensitizes colorectal cancer cells to 5-fluorouracil
Hong, C., Zheng, J., & Li, X. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3282-0 · Cited by 27
“The IPTG-inducible shRNA vectors were performed as previously described [11].”
MethodMoudrá, A., Hubáčková, S., Machalová, V., Vančurová, M., Bártek, J., Reiniš, M., Hodný, Z., & Jonasova, A. T. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1183860 · Cited by 28
“MDS low risk group number of patients 94 number of samples 125 number of patients with multiple BM aspirations 31 patient age at BM aspiration (years), median (range) 72 (46-86) males/females 54 / 71”
BackgroundING3 is required for ATM signaling and DNA repair in response to DNA double strand breaks
Mouche, A., Archambeau, J., Ricordel, C., Chaillot, L., Bigot, N., Guillaudeux, T., Grenon, M., & Pedeux, R. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0305-x · Cited by 32
Jia, H., Cong, Q., Chua, J., Liu, H., Xia, X., Zhang, X., Lin, J., Habib, S. L., Ao, J., Zuo, Q., et al. (2014) · Oncogene · doi:10.1038/onc.2014.287 · Cited by 26
Post-Translational Regulation of ARF: Perspective in Cancer
Seo, J., Seong, D., Lee, S. R., Oh, D., & Song, J. (2020) · Biomolecules · doi:10.3390/biom10081143 · Cited by 28
“Recently, another DNA damage response pathway—the ataxia telangiectasia mutated (ATM)-mediated pathway—has been identified as a novel signaling pathway that regulates ARF localization by modulating serine/threonine-protein kinase Nek 2 (Nek2)-dependent NPM phosphorylation [85].”
BackgroundMesenchymal Stem Cell Senescence and Osteogenesis
Tjempakasari, A., Suroto, H., & Santoso, D. (2021) · Medicina · doi:10.3390/medicina58010061 · Cited by 29
Clinically Applicable Inhibitors Impacting Genome Stability
Prakash, A., García-Moreno, J. F., Brown, J. A. L., & Bourke, E. (2018) · Molecules · doi:10.3390/molecules23051166 · Cited by 26
“Interestingly, in addition to Nek2’s centrosomal role, there is Nek2-dependent activation of Alternative Reading Frame (ARF) protein in response to ATM depletion, which acts as a secondary protective checkpoint response in ATM-deficient cells [73].”
BackgroundYang, Q., Pan, Q., Li, C., Xu, Y., Wen, C., & Sun, F. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.29 · Cited by 23
“phosphorylation of nucleophosmin (NPM), leading to the liberation of p14ARF from NPM to be degraded by the ULF E3-ubiquitin ligase and promoting tumor cell growth.(28)”
BackgroundLi, X., Xun, Z., & Yang, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.112 · Cited by 24
Resistance mechanisms and prospects of trastuzumab
Wang, L., Wang, Y., Li, Y., Zhou, L., Du, J., Wang, J., Liu, S., Cao, Y. L., Li, Y., Yang, W., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1389390 · Cited by 22
SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF
Kumari, P., Tarighi, S., Fuchshuber, E., Li, L., Fernández-Duran, I., Wang, M., Ayoson, J., Castelló-García, J. M., Gámez-García, A., Espinosa‐Alcantud, M., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2409269121 · Cited by 25
“Disruption of NPM–ARF interactions by mutations or posttranslational modifications of NPM rapidly induce ARF degradation promoting tumorigenesis (19–22).”
A short acidic motif in ARF guards against mitochondrial dysfunction and melanoma susceptibility
Christensen, C., Bártková, J., Mistrík, M., Hall, A., Lange, M. K., Ralfkiær, U., Bártek, J., & Guldberg, P. (2014) · Nature Communications · doi:10.1038/ncomms6348 · Cited by 23
Inactivation of the ATMIN/ATM pathway protects against glioblastoma formation
Blake, S. M., Stricker, S. H., Halavach, H., Poetsch, A. R., Cresswell, G. D., Kelly, G. P., Kanu, N., Marino, S., Luscombe, N. M., Pollard, S. M., et al. (2016) · eLife · doi:10.7554/elife.08711 · Cited by 22
“A recent study has, however, demonstrated loss of ATM signaling to inhibit the growth of TP53-null tumor xenografts, via stabilization of p14ARF (Velimezi et al., 2013), suggesting that ATM function in cancer is highly context-dependent.”
BackgroundYang, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.061 · Cited by 21
p19Arf is required for the cellular response to chronic DNA damage
Bieging-Rolett, K. T., Johnson, T. M., Brady, C. A., Beaudry, V. G., Pathak, N., Han, S., & Attardi, L. D. (2016) · Oncogene · doi:10.1038/onc.2015.490 · Cited by 23
“Continued investigation into the complex interplay between the DNA damage response, Arf, and tumor suppression – an ever-evolving area 42, 43 – will ultimately help decipher key tumor suppressor pathways.”
ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer
Owczarek, T. B., Kobayashi, T., Ramirez, R. J., Rong, L., Puzio‐Kuter, A. M., Iyer, G., Teo, M. Y., Sánchez-Vega, F., Wang, J., Schultz, N. D., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2621 · Cited by 19
Wang, F., & Yang, Y. P. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3068-6 · Cited by 18
“ible shRNA vectors were used as previously reported [16].”
RetractedDana, D., Das, T., Choi, A., Bhuiyan, A. I., Das, T. K., Talele, T. T., & Pathak, S. K. (2022) · Molecules · doi:10.3390/molecules27020347 · Cited by 19
“This results in the dissociation of ARF from NPM, and its subsequent degradation by ULF E3-ubiquitin ligase [90,91].”
BackgroundKarambataki, M., Malousi, A., & Kouidou, S. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.09.005 · Cited by 17
Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis
Suguro, M., Yoshida, N., Umino, A., Kato, H., Tagawa, H., Nakagawa, M., Fukuhara, N., Karnan, S., Takeuchi, I., Hocking, T. D., et al. (2014) · Cancer Science · doi:10.1111/cas.12442 · Cited by 16
Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells
Cao, Y., Lin, Y., Wang, D., Pan, D., Zhang, Y., Yu, J. H., & Zheng, C.-Q. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3676-7 · Cited by 15
RASSF1A disrupts the NOTCH signaling axis via SNURF/RNF4‐mediated ubiquitination of HES1
Papaspyropoulos, A., Angelopoulou, A., Mourkioti, I., Polyzou, A., Paňková, D., Toskas, K., Lanfredini, S., Pantazaki, Α. A., Lаgopati, N., Kotsinas, A., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051287 · Cited by 17
Self-citationOncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia
Bellelli, R., Vitagliano, D., Federico, G., Marotta, P., Tamburrino, A., Salerno, P., Paciello, O., Papparella, S., Knauf, J. A., Fagin, J. A., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.023 · Cited by 15
“Similar behaviour has been d scribed in other cancer mouse 1 models (Evangelou et al., 2013, Velimezi et al., 2013).”
MethodARF: a versatile DNA damage response ally at the crossroads of development and tumorigenesis
Kotsinas, A., Papanagnou, P., Evangelou, K., Trigas, G. C., Kostourou, V., Townsend, P. A., & Gorgoulis, V. G. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00236 · Cited by 14
“Another option in order to therapeutically exploit the aforementioned ARF/VEGF pathway would be the usage of synthetic ARF peptides comprising ARF’s amino-terminal residues 2–14 that mediate all the biological effects of ARF, including the antigrowth ones (Saporita et al., 2007).”
BackgroundMethodSelf-citationMechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex
Carrà, G., Crivellaro, S., Taulli, R., Guerrasio, A., Saglio, G. N., & Morotti, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17121997 · Cited by 18
“On the one hand, p53 inactivation either through mutations or aberrant regulations may bring out novel targets, as was recently pointed out with the DNA damage pathway and Arf regulation [86].”
Kotsinas, A., Papanagnou, P., Galanos, P., Schramek, D., Townsend, P. A., Penninger, J. M., Bártek, J., & Gorgoulis, V. G. (2014) · Cell Cycle · doi:10.4161/cc.28654 · Cited by 13
“Of note, in p53-null cellular and xenograft models, the ATM-dependent ARF upregulation indeed restrained ribogenesis and cell cycle progression, supporting the biological significance of the deciphered ATM/ ARF link.(9,30,31) Also, in human clinical samples, loss of ATM expression correlated with increased ARF levels,…”
BackgroundSelf-citationBártková, J., Hoei‐Hansen, C. E., Křížová, K., Hamerlik, P., Skakkebæk, N. E., Meyts, E. R., & Bártek, J. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.001 · Cited by 16
Wiesmann, N., Gieringer, R., Grus, F. H., & Brieger, J. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.10.015 · Cited by 13
“[8] Velimezi G, Liontos M, Vougas K, Roumeliotis T, Bartkova J, Sideridou M,”
Knockdown of CDK2AP1 in Primary Human Fibroblasts Induces p53 Dependent Senescence
Alsayegh, K. N., Gadepalli, V. S., Iyer, S., & Rao, R. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120782 · Cited by 12
“Therefore, in future experiments, it would be useful to attempt to reverse the senescence observed in CDK2AP1 knockdown primary human fibroblasts by downregulating p14 or ATM, given that the DNA damage response (DDR) pathway via ATM activation and ARF are stress responders and activate p53, while ATM also keeps in che…”
BackgroundTao, Y., Mei, Y., Ying, R., Chen, S., & Wei, Z. (2020) · Gene · doi:10.1016/j.gene.2020.144578 · Cited by 11
Metadata
- Authors
- Velimezi, G., Liontos, M., Vougas, K., Roumeliotis, T., Bartkova, J., Sideridou, M., Dereli-Oz, A., Kocylowski, M., Pateras, I. S., Evangelou, K., Kotsinas, A., Orsolic, I., Bursac, S., Cokaric-Brdovcak, M., Zoumpourlis, V., Kletsas, D., Papafotiou, G., Klinakis, A., Volarevic, S., Gu, W., Bartek, J., Halazonetis, T. D., & Gorgoulis, V. G.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Biomedical Research Foundation of the Academy of Athens (GR)
- University of Geneva (CH)
- Danish Cancer Society (DK)
- National Hellenic Research Foundation (GR)
- National Centre of Scientific Research "Demokritos" (GR)
- Columbia University (US)
- Corresponding author
- Gorgoulis, Vassilis G.
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2013-07-14
- Volume
- 15
- Issue
- 8
- Pages
- 967-977
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2039467788
- Cited by
- 131
- References
- 75
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 7 · 2020: 9 · 2019: 6 · 2018: 14 · 2017: 11 · 2016: 28 · 2015: 14 · 2014: 20 · 2013: 5
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-10-01)
- Open access
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- ATM kinase, DNA damage response, tumor suppression, protein phosphatase 1, NEK2, protein degradation, oncogene-transformed cells, carcinogenesis, ATM inhibition
- MeSH terms
- NIMA-Related Kinases, Animals, Carrier Proteins, Cell Cycle, Cell Line, DNA-Binding Proteins, HeLa Cells, Humans, Male, Neoplasms, Phosphorylation, Ribosomes, Transplantation, Heterologous, Signal Transduction, Gene Expression Regulation, Neoplastic, Protein Serine-Threonine Kinases, Cell Cycle Proteins, ADP-Ribosylation Factor 1, Tumor Suppressor Protein p14ARF, Ubiquitin-Protein Ligases, Cell Line, Tumor, Mice, Protein Stability, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.